InterCloud Announces Conference Call to Discuss Third

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
InterCloud Announces Conference Call to Discuss Third Quarter 2016 Financial Results

SHREWSBURY, N.J., Nov. 07, 2016 (GLOBE NEWSWIRE) -- InterCloud Systems Inc. (OTCQB:ICLD) ("InterCloud" or the "Company"), a leading provider of cloud networking orchestration and automation solutions and services will hold a conference call to discuss its financial results for the Third Quarter 2016. CEO Mark Munro and CFO Tim Larkin will participate in the call, which is scheduled for Thursday, November 10, 2016, at 10:00 a.m. Eastern time.

To participate in the call, please dial 1-888-419-6591 or 1-719-325-4901 for international calls, approximately 10 minutes prior to the scheduled start time.  The Conference ID number is 3351493. A replay of the call will be available for two weeks beginning 1:00 p.m. ET on November 10, 2016. The number for the replay is: 1-844-512-2921, or 1-412-317-6671 for international calls; the passcode for the replay is 3351493.

About InterCloud Systems, Inc.

InterCloud Systems, Inc. is a leading provider of cloud networking orchestration and automation, for Software Defined Networking (SDN) and Network Function Virtualization (NFV) cloud environments to the telecommunications service provider (carrier) and corporate enterprise markets through cloud solutions and professional services. InterCloud's cloud solutions offer enterprise and service-provider customers the opportunity to adopt an operational expense model by outsourcing cloud deployment and management to InterCloud rather than the capital expense model that has dominated in recent decades in IT infrastructure management. Additional information regarding InterCloud may be found on InterCloud's website at www.intercloudsys.com .

Forward-looking statements:

The above release contains forward-looking statements. The statements contained in this document that are not statements of historical fact, including but not limited to, statements identified by the use of terms such as "anticipate," "appear," "believe," "could," "estimate," "expect," "hope," "indicate," "intend," "likely," "may," "might," "plan," "potential," "project," "seek," "should," "will," "would," and other variations or negative expressions of these terms, including statements related to expected market trends and the Company's performance, are all "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve a number of risks and uncertainties. These statements are based on assumptions that management believes are reasonable based on currently available information, and include statements regarding the intent, belief or current expectations of the Company and its management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performances, and are subject to a wide range of external factors, uncertainties, business risks, and other risks identified in filings made by the company with the Securities and Exchange Commission. Actual results may differ materially from those indicated by such forward-looking statements. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based except as required by applicable law and regulations.

CONTACT: Investor Relations InterCloud Systems, Inc. 561-988-1988

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 72

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 105

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 337

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 508

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 83

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 727

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 248

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 587

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 171

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 341

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading

Top 5 Most Recently Viewed Articles

Introducing the Innovative Garage Door Opener for Homes

Updated Category News Views 201

Introducing the G3120HL Garage Door Opener Modern Design with Advanced Features – Beyond Basic. Built for More. MT. HOPE, Ohio — Genie®, known for its exceptional garage door innovations, has launched the G3120HL opener, fusing cutting-edge technology with an impressive industrial design. This opener enhances security, convenience, and durability, perfectly suited...

Continue Reading
Costamare Inc. Announces Latest Dividends for Investors

Updated Category News Views 68

Costamare Inc. (NYSE: CMRE) dropped a bombshell back in 2024, announcing hefty cash dividends that had traders buzzing. They laid out payments of US $0.476563 per share for the 7.625% Series B Cumulative Redeemable Perpetual Preferred Stock, US $0.531250 for the 8.50% Series C, and US $0.546875 per share for the 8.75% Series D Preferred Stock. For investors eyeing a...

Continue Reading
TranscribeGlass Expands Orders for Vuzix Smart Glasses

Updated Category News Views 159

TranscribeGlass Orders More Vuzix Z100 Smart Glasses AI-driven speech-to-text technology is revolutionizing how we communicate. For those who are deaf or hard of hearing, this technology enhances accessibility and allows for real-time closed captions in various environments. Continued Demand for Transcription Solutions The demand for effective communication solutions is...

Continue Reading
Sandoz Q1 2025 Financial Performance Highlights and Insights

Updated Category News Views 544

Sandoz Reports Robust Q1 2025 Financials Sandoz has shared its financial updates for the first quarter of 2025, reflecting a strong performance that aligns well with the company's expectations. This report is particularly notable as it confirms the company's ongoing commitment to delivering high-quality generic and biosimilar medicines to global markets. Q1 Sales...

Continue Reading
Zero Candida Technologies Expands Investor Access and DTC Eligibility

Updated Category News Views 124

Exciting Developments from Zero Candida Technologies Zero Candida Technologies, Inc. (ZCT) is making significant strides in revolutionizing women's health with their innovative medical device approach. This FemTech company has recently announced that its common shares are now eligible for Depository Trust Company (DTC) electronic clearing and settlement services. This...

Continue Reading